Delphia Therapeutics raised $67M in a Series A financing led by GV, Nextech Invest, Polaris Innovation Fund, and Alexandria Venture Investments to pioneer activation lethality in cancer medicines.
Amount Raised
$67 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Delphia Therapeutics launched to pioneer a new area of cancer biology called activation lethality, to develop first-in-class targeted cancer medicines with significant anti-tumor activity and more durable patient benefit.
Quick answer
Delphia Therapeutics raised $67 Million in a Series A round, dated May 2, 2024. Investors: GV, Alexandria Venture Investments, Polaris Innovation Fund and Nextech Invest. Delphia Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Delphia Therapeutics raise?
- Delphia Therapeutics raised $67 Million in a Series A round on May 2, 2024.
- Who invested in Delphia Therapeutics?
- GV, Alexandria Venture Investments, Polaris Innovation Fund and Nextech Invest are named as investors in this round.
- What does Delphia Therapeutics do?
- Delphia Therapeutics is a biopharmaceutical company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation.
- Where is Delphia Therapeutics based and how big is it?
- Delphia Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 27 employees.
- Who are the decision-makers at Delphia Therapeutics?
- Fundz holds 2 contacts at Delphia Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Delphia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- InduPro raised $85M (Series A) on June 13, 2024.
- Amber Therapeutics raised $100M (Series A) on June 10, 2024.
- Calidi Biotherapeutics raised $5.5M on June 3, 2024.
- Summit Therapeutics raised $200M on June 3, 2024.
- Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
- Radiomer Therapeutics raised an undisclosed amount (Pre-Seed) on May 29, 2024.
Who to call at Delphia Therapeutics, and when
A new round usually means Delphia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Delphia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Delphia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Delphia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Delphia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDelphia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.